179 related articles for article (PubMed ID: 27690341)
21. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.
Tan D; Li Q; Deeb G; Ramnath N; Slocum HK; Brooks J; Cheney R; Wiseman S; Anderson T; Loewen G
Hum Pathol; 2003 Jun; 34(6):597-604. PubMed ID: 12827614
[TBL] [Abstract][Full Text] [Related]
22. Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li B; Lan J; Liang S; Shen B; Lei Z; Zheng W
Diagn Pathol; 2015 Jul; 10():101. PubMed ID: 26168791
[TBL] [Abstract][Full Text] [Related]
23. Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy.
Brady AK; McNeill JD; Judy B; Bauml J; Evans TL; Cohen RB; Langer C; Vachani A; Aggarwal C
Oncotarget; 2015 Oct; 6(30):30287-94. PubMed ID: 26471290
[TBL] [Abstract][Full Text] [Related]
24. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy.
Sadi MV; Walsh PC; Barrack ER
Cancer; 1991 Jun; 67(12):3057-64. PubMed ID: 1710537
[TBL] [Abstract][Full Text] [Related]
26. Post-recurrence survival analysis of stage I non-small-cell lung cancer.
Lee K; Kim HR; Kim DK; Kim YH; Park SI; Choi SH; Han J
Asian Cardiovasc Thorac Ann; 2017 Nov; 25(9):623-629. PubMed ID: 29058973
[TBL] [Abstract][Full Text] [Related]
27. The prognostic impact of tumor cell expression of estrogen receptor-α, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer.
Rades D; Setter C; Dahl O; Schild SE; Noack F
Cancer; 2012 Jan; 118(1):157-63. PubMed ID: 21713768
[TBL] [Abstract][Full Text] [Related]
28. Heat shock protein 90-β over-expression is associated with poor survival in stage I lung adenocarcinoma patients.
Wu Y; Huang B; Liu Q; Liu Y
Int J Clin Exp Pathol; 2015; 8(7):8252-9. PubMed ID: 26339394
[TBL] [Abstract][Full Text] [Related]
29. High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLC.
Oh MS; Anker JF; Chae YK
Cancer Treat Res Commun; 2021; 27():100317. PubMed ID: 33711637
[TBL] [Abstract][Full Text] [Related]
30. High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.
Ludovini V; Bellezza G; Pistola L; Bianconi F; Di Carlo L; Sidoni A; Semeraro A; Del Sordo R; Tofanetti FR; Mameli MG; Daddi G; Cavaliere A; Tonato M; Crinò L
Ann Oncol; 2009 May; 20(5):842-9. PubMed ID: 19153117
[TBL] [Abstract][Full Text] [Related]
31. Yes associated protein is a poor prognostic factor in well-differentiated lung adenocarcinoma.
Kim MH; Kim YK; Shin DH; Lee HJ; Shin N; Kim A; Lee JH; Choi KU; Kim JY; Lee CH; Sol MY
Int J Clin Exp Pathol; 2015; 8(12):15933-9. PubMed ID: 26884866
[TBL] [Abstract][Full Text] [Related]
32. Androgen receptor as a prognostic biomarker and therapeutic target in uterine leiomyosarcoma.
Baek MH; Park JY; Park Y; Kim KR; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
J Gynecol Oncol; 2018 May; 29(3):e30. PubMed ID: 29533018
[TBL] [Abstract][Full Text] [Related]
33. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors.
Nasser SM; Faquin WC; Dayal Y
Am J Clin Pathol; 2003 Jun; 119(6):801-6. PubMed ID: 12817426
[TBL] [Abstract][Full Text] [Related]
34. High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis.
Thomas A; Chen Y; Steinberg SM; Luo J; Pack S; Raffeld M; Abdullaev Z; Alewine C; Rajan A; Giaccone G; Pastan I; Miettinen M; Hassan R
Oncotarget; 2015 May; 6(13):11694-703. PubMed ID: 26028668
[TBL] [Abstract][Full Text] [Related]
35. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
36. IMP3 can predict aggressive behaviour of lung adenocarcinoma.
Beljan Perak R; Durdov MG; Capkun V; Ivcevic V; Pavlovic A; Soljic V; Peric M
Diagn Pathol; 2012 Nov; 7():165. PubMed ID: 23190601
[TBL] [Abstract][Full Text] [Related]
37. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
Xu XY; Lin N; Li YM; Zhi C; Shen H
Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
[TBL] [Abstract][Full Text] [Related]
38. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
Reck M; Kaiser R; Mellemgaard A; Douillard JY; Orlov S; Krzakowski M; von Pawel J; Gottfried M; Bondarenko I; Liao M; Gann CN; Barrueco J; Gaschler-Markefski B; Novello S;
Lancet Oncol; 2014 Feb; 15(2):143-55. PubMed ID: 24411639
[TBL] [Abstract][Full Text] [Related]
39. Androgen receptor expression inversely correlates with histological grade and N stage in ER
Scatena C; Scarpitta R; Innocenti L; Miccoli M; Biancotti R; Diodati L; Ghilli M; Naccarato AG
Breast Cancer Res Treat; 2020 Jul; 182(1):55-65. PubMed ID: 32436149
[TBL] [Abstract][Full Text] [Related]
40. Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration.
Kadota K; Eguchi T; Villena-Vargas J; Woo KM; Sima CS; Jones DR; Travis WD; Adusumilli PS
Oncotarget; 2015 Sep; 6(29):27505-18. PubMed ID: 26318038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]